Capital World Investors »

Cytokinetics shares owned by Capital World Investors

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Capital World Investors from 13F filings

Historical chart of Capital World Investors investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Capital World Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Capital World Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $16M 242k 65.91

More positions owned by Capital World Investors

Broadcom (AVGO)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Philip Morris International (PM)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Micron Technology (MU)
Alphabet Cap Stk Cl C (GOOG)
Vertex Pharmaceuticals Incorporated (VRTX)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Amgen (AMGN)
Canadian Natural Resources (CNQ)

View all positions for Capital World Investors

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Bank of America Corporation
Susquehanna International
Rtw Investments
Armistice Capital
Goldman Sachs Group
Polar Capital Holdings

View all funds holding Cytokinetics